PTC Therapeutics Inc
NASDAQ:PTCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
Silicon Motion Technology Corp
NASDAQ:SIMO
|
TW |
|
P
|
Publicis Groupe SA
OTC:PGPEF
|
FR |
|
K
|
KLA Corp
XMUN:KLA
|
US |
|
M
|
Mitsui & Co Ltd
XMUN:MTS1
|
JP |
|
M
|
MS&AD Insurance Group Holdings Inc
XMUN:59M
|
JP |
Wall St Price Targets
PTCT Price Targets Summary
PTC Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for PTCT is 92.75 USD with a low forecast of 65.65 USD and a high forecast of 130.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PTCT's stock price target?
Price Target
92.75
USD
According to Wall Street analysts, the average 1-year price target for PTCT is 92.75 USD with a low forecast of 65.65 USD and a high forecast of 130.2 USD.
What is the Revenue forecast for PTC Therapeutics Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 3 years is -2%.
What is the Gross Profit forecast for PTC Therapeutics Inc?
Projected CAGR
-5%
The compound annual growth rate for Gross Profit over the next 3 years is -5%.
What is the Operating Income forecast for PTC Therapeutics Inc?
Projected CAGR
-12%
The compound annual growth rate for Operating Income over the next 3 years is -12%.
What is the Pre-Tax Income forecast for PTC Therapeutics Inc?
Projected CAGR
-20%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -20%.
What is the Net Income forecast for PTC Therapeutics Inc?
Projected CAGR
-20%
Over the last 13 years, the compound annual growth rate for Net Income has been 70%. The projected CAGR for the next 3 years is -20%.
